Skip to content

Clinical trials

Cardiomyopathies trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathies Country / region: United Kingdom Clear all

50 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20042
20051
20061
20071
20112
20121
20145
20152
20185
20195
20204
20214
20222
20235
20243
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Recruiting14
Unknown status6
Active, not recruiting4
Terminated3
Enrolling by invitation2
Withdrawn1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alnylam Pharmaceuticals7
Imperial College London5
Barts & The London NHS Trust2
Bayer2
Eidos Therapeutics, a BridgeBio company2
Intellia Therapeutics2
Ionis Pharmaceuticals, Inc.2
King's College London2
NHS Greater Glasgow and Clyde2
Rocket Pharmaceuticals Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathies50
Heart Failure15
Amyloidosis10
Heart Diseases8
Cardiomyopathy, Hypertrophic7
Cardiomyopathy, Dilated6
Alzheimer Disease5
Amyloid Neuropathies, Familial4
Amyloidosis, Familial3
Arrhythmias, Cardiac3

Trials

Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.